drugset / Trial / NCT02060552
Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of study was to assess the efficiency and safety of oral IL-1βinhibitor in combination with urate lowering therapy on joint pain intensity,urate control, global assessments of disease activity, self-monitored gouty acute flare times, inflammatory markers and symptoms improving related life quantity in gouty patients.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-03
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 0.5 mg | — |
| Subject | Diacerein | Small molecule | 50 mg | Oral |
| Background | Febuxostat | Small molecule | 40 mg | — |